
Ten63 Therapeutics
Ten63 Therapeutics builds BEYOND, the world's first Large Quantum Chemistry Model — pairing generative chemistry at scale with quantum-accurate simulation (Superlearning) to design therapeutics for previously undruggable and under-drugged targets.
$15.9M Series A ·
Source: fundraisingfox.com
All 2 rounds ↓Signals
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $15.9M | — | fundraisingfox.com |
Timeline
- Website created
- IndieBio SF 08
IIndieBio · batchSource: indiebio.co
Founders and team
MF
Marcel Frenkel Foundersource: ten63tx.comMH
Mark Hallen Foundersource: ten63tx.com
Investors
Companies like Ten63 Therapeutics
OOratomic$475M Series B+ · Oct 2026
WWayfinder BiosciencesBBQP$4.8M Seed · Jul 2025
FFrontier MedicinesSeries B+ · Aug 2025
MManas AI$26M Seed · Sep 2025
MMatchpoint Therapeutics$150M Series B+ · Oct 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/ten63-therapeutics (get a free API key).